<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for Calendar Year or Quarter Ended: September 30, 2000
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings
entries.
Institutional Investment Manager Filing this Report:
Name: BB Biotech AG
Address: Vordergasse 3
Grafenauweg 4
Zug, Switzerland CH-6301
Form 13F File Number: 28-6964
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Dubravka Racnjak
Title: SIGNING AUTHORITY
------------------
Phone: (41-41) 724-5959
Signature, Place, and Date of Signing:
/s/ Dubravka Racnjak Zug, Switzerland November 9, 2000
<PAGE> 2
Report Type (Check only one.):
[ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting
manager are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
[X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported
by other reporting manager(s).)
List of Other Managers Reporting for this Manager:
Name
Biotech Focus S.A.
Biotech Invest S.A.
Biotech Target S.A.
Biotech Growth S.A.
<PAGE> 3
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 4
Form 13F Information Table Entry Total: 24
Form 13F Information Table Value Total: $3,287,931
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
<TABLE>
<CAPTION>
No. Name
<S> <C>
1 Biotech Focus S.A.
2 Biotech Invest S.A.
3 Biotech Target S.A.
4 Biotech Growth S.A.
</TABLE>
<PAGE> 4
BB BIOTECH AG
FORM 13F INFORMATION TABLE
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------------------------------------------------------
COLUMN 8:
COLUMN 5: VOTING AUTHORITY
COLUMN 4: COLUMN 6:
COLUMN 1: COLUMN 2: COLUMN 3: VALUE ------------------------ INVESTMENT COLUMN 7: ---------------------------
NAME OF ISSUER TITLE OF CLASS CUSIP (X$1,000) SHRS OR SH/ PUT/ DISCRETION OTHER
PRN AMT PRN CALL MANAGERS
SOLE SHARED NONE
-----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Alexion
Pharmaceuticals,
Inc. Common Stock 01535110 $ 207,948 1,824,113 SH DEFINED 3 1,824,113 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Amgen Inc. Common Stock 00075886F1 $ 96,365 1,380,000 SH DEFINED 1 1,380,000 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Aviron Common Stock 05376210 $ 154,829 2,655,286 SH DEFINED 2 2,655,286 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Biogen Inc. Common Stock 090597105 $ 37,972 622,500 SH DEFINED 1 622,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
CV
Therapeutics,
Inc. Common Stock 12666710 $ 166,421 2,139,647 SH DEFINED 3 2,139,647 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Celgene Corp. Common Stock 151020104 $ 90,737 1,525,000 SH DEFINED 2 1,525,000 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Pe-Celera
Genomics Common Stock 69332S201 $ 39,852 400,000 SH DEFINED 2 400,000 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Cell
Therapeutics,
Inc. Common Stock 150934107 $ 56,719 850,500 SH DEFINED 3 850,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
3-Dimensional
Pharmaceuticals,
Inc. Common Stock 88554W104 $ 110,290 3,063,632 SH DEFINED 4 3,063,632 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Durect
Corporation Common Stock 266605104 $ 34,017 2,267,857 SH DEFINED 4 2,267,857 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Endo
Pharmaceuticals,
Inc. Common Stock 29264P104 $ 14,219 1,449,500 SH DEFINED 3 1,449,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Genentech Common Stock 368710406 $ 241,433 1,300,197 SH DEFINED 1 1,300,197 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
IDEC
Pharmaceuticals Common Stock 449370105 $ 409,728 2,336,500 SH DEFINED 1 2,336,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Imclone Common Stock 45245W109 $ 119,693 1,022,500 SH DEFINED 2 1,022,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Immunex Corp. Common Stock 452528102 $ 33,756 776,000 SH DEFINED 1 776,000 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Medicines
Company (The) Common Stock 584688105 $ 177,953 5,204,837 SH DEFINED 4 5,204,837 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
MedImmune Common Stock 58469910 $ 884,976 11,456,000 SH DEFINED 1 11,456,000 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Neurocrine
Biosciences Common Stock 64125C109 $ 49,207 1,093,500 SH DEFINED 3 1,093,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
NexMed, Inc. Common Stock 652903105 $ 6,713 342,000 SH DEFINED 3 342,000 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Pharmacopeia Inc. Common Stock 71713B104 $ 26,864 1,053,500 SH DEFINED 2 1,053,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Transkaryotic
Therapies Common Stock 89373510 $ 121,063 2,811,500 SH DEFINED 2 2,811,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Trimeris Inc. Common Stock 896263100 $ 55,231 789,700 SH DEFINED 3 789,700 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
United
Therapeutics Common Stock 91307C102 $ 91,093 1,042,500 SH DEFINED 2 1,042,500 NONE NONE
-----------------------------------------------------------------------------------------------------------------------------------
Virologic Common Stock 92823R201 $ 60,852 3,605,005 SH DEFINED 4 3,605,005 NONE NONE
COLUMN
TOTALS $3,287,931
-----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
